Your browser doesn't support javascript.
loading
Guillain-Barré syndrome after vaccination against COVID-19.
Chun, June Young; Park, Sohyun; Jung, Jongheon; Kim, Su-Hyun; Kim, Tae-Sung; Choi, Young Ju; Kim, Ho Jin; Eom, Hyeon-Seok; Hyun, Jae-Won.
Afiliación
  • Chun JY; Division of Infectious Disease, Department of Internal Medicine, Research Institute and Hospital of National Cancer Center, Goyang 10408, South Korea.
  • Park S; Department of Nuclear Medicine, Research Institute and Hospital of National Cancer Center, Goyang 10408, South Korea.
  • Jung J; Department of Hemato-oncology, Research Institute and Hospital of National Cancer Center, Goyang 10408, South Korea.
  • Kim SH; Center for Hematologic Malignancy, and Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang 10408, South Korea.
  • Kim TS; Department of Nuclear Medicine, Research Institute and Hospital of National Cancer Center, Goyang 10408, South Korea.
  • Choi YJ; Division of Infectious Disease, Department of Internal Medicine, Research Institute and Hospital of National Cancer Center, Goyang 10408, South Korea.
  • Kim HJ; Center for Hematologic Malignancy, and Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang 10408, South Korea.
  • Eom HS; Department of Hemato-oncology, Research Institute and Hospital of National Cancer Center, Goyang 10408, South Korea. Electronic address: hseom@ncc.re.kr.
  • Hyun JW; Center for Hematologic Malignancy, and Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang 10408, South Korea. Electronic address: jacksy12@naver.com.
Lancet Neurol ; 21(2): 117-119, 2022 02.
Article en En | MEDLINE | ID: mdl-34929194
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Guillain-Barré / Vacunas contra la COVID-19 Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Lancet Neurol Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Guillain-Barré / Vacunas contra la COVID-19 Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Lancet Neurol Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Reino Unido